dalteparin and cgp 39393

dalteparin has been researched along with cgp 39393 in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (71.43)18.2507
2000's1 (14.29)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Biemond, BJ; Büller, HR; Levi, M; Nurmohamed, MT; ten Cate, JW1
Eriksson, BI; Kälebo, P; Magnusson, M; Sivertsson, R1
Bach, D; Baur, M; Bösch, P; Close, P; Ekman, S; Eriksson, BI; Kälebo, P; Lindbratt, S; Mouret, P; Rosencher, N; Wille-Jørgensen, P1
Ewenstein, BM1
Robb, J1
Bonneau, JC; Drouet, M; Gay, G; Le Sellin, J; Leclere, JM; Nicolie, B1
Eriksson, BI; Jaffer, AK; Shorr, AF; Smith, J1

Reviews

1 review(s) available for dalteparin and cgp 39393

ArticleYear
[Delayed hypersensitivity to heparins and heparinoids].
    Allergie et immunologie, 2002, Volume: 34, Issue:2

    Topics: Aged; Anticoagulants; Chondroitin Sulfates; Cross Reactions; Dalteparin; Dermatan Sulfate; Drug Combinations; Drug Hypersensitivity; Enoxaparin; Female; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Hypersensitivity, Delayed; Nadroparin; Recombinant Proteins; Skin Tests

2002

Trials

1 trial(s) available for dalteparin and cgp 39393

ArticleYear
A comparison of recombinant hirudin with a low-molecular-weight heparin to prevent thromboembolic complications after total hip replacement.
    The New England journal of medicine, 1997, Nov-06, Volume: 337, Issue:19

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Hip; Double-Blind Method; Enoxaparin; Female; Hirudin Therapy; Hirudins; Humans; Male; Middle Aged; Postoperative Complications; Recombinant Proteins; Thrombophlebitis; Treatment Outcome

1997

Other Studies

5 other study(ies) available for dalteparin and cgp 39393

ArticleYear
Additive effect of the combined administration of low molecular weight heparin and recombinant hirudin on thrombus growth in a rabbit jugular vein thrombosis model.
    Thrombosis and haemostasis, 1994, Volume: 72, Issue:3

    Topics: Animals; Blood Coagulation; Drug Synergism; Drug Therapy, Combination; Factor Xa Inhibitors; Fibrinolytic Agents; Hirudin Therapy; Hirudins; Infusions, Intravenous; Jugular Veins; Nadroparin; Rabbits; Recombinant Proteins; Thrombin; Thrombosis

1994
Is colour Doppler ultrasound a sensitive screening method in diagnosing deep vein thrombosis after hip surgery?
    Thrombosis and haemostasis, 1996, Volume: 75, Issue:2

    Topics: Anticoagulants; Dalteparin; Dextrans; Hip Fractures; Hip Prosthesis; Hirudin Therapy; Hirudins; Humans; Incidence; Phlebography; Postoperative Care; Postoperative Complications; Predictive Value of Tests; Recombinant Proteins; Risk; Sensitivity and Specificity; Thrombophlebitis; Ultrasonography, Doppler, Color

1996
Antithrombotic agents and thromboembolic disease.
    The New England journal of medicine, 1997, Nov-06, Volume: 337, Issue:19

    Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Enoxaparin; Fibrinolytic Agents; Hirudin Therapy; Hirudins; Humans; Postoperative Complications; Recombinant Proteins; Thrombophlebitis

1997
Recombinant hirudin compared with low-molecular-weight heparin to prevent thromboembolic complications after total hip replacement.
    The New England journal of medicine, 1998, Mar-26, Volume: 338, Issue:13

    Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Enoxaparin; Hirudin Therapy; Hirudins; Humans; Postoperative Complications; Recombinant Proteins; Thrombophlebitis

1998
Impact of stage 3B chronic kidney disease on thrombosis and bleeding outcomes after orthopedic surgery in patients treated with desirudin or enoxaparin: insights from a randomized trial.
    Journal of thrombosis and haemostasis : JTH, 2012, Volume: 10, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Hip; Drug Administration Schedule; Enoxaparin; Female; Hirudins; Humans; Injections, Subcutaneous; Logistic Models; Male; Middle Aged; Multicenter Studies as Topic; Odds Ratio; Patient Selection; Postoperative Hemorrhage; Randomized Controlled Trials as Topic; Recombinant Proteins; Renal Insufficiency, Chronic; Retrospective Studies; Risk Assessment; Risk Factors; Severity of Illness Index; Thrombosis; Time Factors; Treatment Outcome; Young Adult

2012